Trial intelligence / Profile preview

Liraglutide in Obese Women With PCOS

NCT01899430Phase 4Completed

Sponsor
University Medical Centre Ljubljana
Start
Nov 2011
Primary completion
Oct 2012
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of liraglutide in polycystic ovary syndrome (PCOS), obesity, sponsored by University Medical Centre Ljubljana. Started Nov 2011; status: completed.

02

Drugs

03

Conditions

polycystic ovary syndrome (PCOS)obesity

Beyond the preview

Go deeper on NCT01899430.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01899430.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call